Clinical Research Services Market Analysis and Forecast 2018-2024
Clinical research services market from Qurate’s Repository entails insightful data, comprehensive analysis and thorough information derived from research monitored by team of experts and analysts.
(EMAILWIRE.COM, August 02, 2018 ) Clinical research services market: Clinical research is a branch of healthcare that studies whether a medical strategy, medicine, medical device, diagnostics and treatment regimes is safe and effective for human use. Clinical research may contribute to treatment, prevention, diagnosis or relieving certain symptoms of disease or condition. Clinical research is carried out with a pool of patients or people under study condition. Clinical research is a broad term which includes many research studies such as treatment, prevention, diagnostic, screening, genetic, epidemiological and clinical trial studies.
Global Market Outline: Clinical Research Services Market
Global clinical research services market is driven by increased burden of chronic diseases such as HIV, cancer and cardio vascular diseases, which requires huge investments. Pharmaceutical and biotechnological companies outsource their clinical research activities to clinical research service organizations to reduce the cost and regulatory burdens. In addition, enormous growth in biopharmaceutical segment, discovery of the new drugs through innovation and increase in clinical trials are expected to boost the clinical research services market over the forecast period. However, increase in clinical research costs, stringent regulatory procedures and ethical issues are hindering the clinical research services market.
Request Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-PBI-HnM-3219
Clinical research services market has been segmented based on type of service, therapeutic area, end user, and region
Based on type of service, clinical research services market is segmented into
Treatment Research
Prevention Research
Diagnostic Research
Screening Research
Quality of LifeResearch
Genetic studies
Epidemiological studies
Clinical Trials
Others
Base on disease area, clinical research services market is segmented into
Oncology
Central Nervous System Disorders
Cardio Vascular Disorders
Diabetes
Infectious Diseases
Others
Based on end-user, clinical research services market is segmented into
Pharmaceutical Companies
Biotechnological Companies
Research Organizations
Others
Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-PBI-HnM-3219
Clinical research services market is at steady stage of growth. The market is expected to grow at a significant rate during the forecast period. Market players are expanding their markets by offering various services and collaborations. For instance in June 2018, PAREXEL International Corporation, a leading global biopharmaceutical services organization, collaborated with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials. Moreover, In order to maintain market position, companies adopting mergers and acquisitions as their key strategies. For instance, in May, 2018 and inVentiv Health, Inc. and INC Research Holdings, Inc., announced a definitive merger agreement to create a leading biopharmaceutical solutions organization. Similarly, in April 2017, Charles River Laboratories acquired WIL Research to enhance its global footprint, scientific capabilities, and access to growing market segments.
Geographically clinical research services market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America clinical research services market expected to be leading clinical research services market owing to factors such as favourable regulations, developed infrastructure, increase in research and development activities and availability of pool of patients. Europe clinical research services market expected to grow at significant rate owing to increase in R&D activities by pharma and biotechnological companies and favourable regulatory environment and government policies. Asia Pacific region clinical research services market is expected to be fastest growing owing to developing regulatory policies, low cost of the research and availability of a large number of patients.
Some of the players in Clinical Research Services market are Laboratory Corporation Of America Holdings (U.S.), Quintiles Transnational Holdings Inc. (U.S.), PAREXEL International Corporation (U.S.), ICON Plc (Ireland), PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Wuxi AppTec (Cayman) Inc. (China), Pharmaceutical Product Development, LLC (U.S.), INC Research Holdings Inc. (U.S.), and Charles River Laboratories International Inc. (U.S.), to name a few.
In October 2015, WuXi PharmaTech (Cayman) Inc. and Gilead Sciences, Inc., strategically partnered in conducting analytical and stability studies of small-molecule new chemical entities to support global marketing applications and commercial products.
Enquiry for Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-PBI-HnM-3219
Global Market Outline: Clinical Research Services Market
Global clinical research services market is driven by increased burden of chronic diseases such as HIV, cancer and cardio vascular diseases, which requires huge investments. Pharmaceutical and biotechnological companies outsource their clinical research activities to clinical research service organizations to reduce the cost and regulatory burdens. In addition, enormous growth in biopharmaceutical segment, discovery of the new drugs through innovation and increase in clinical trials are expected to boost the clinical research services market over the forecast period. However, increase in clinical research costs, stringent regulatory procedures and ethical issues are hindering the clinical research services market.
Request Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-PBI-HnM-3219
Clinical research services market has been segmented based on type of service, therapeutic area, end user, and region
Based on type of service, clinical research services market is segmented into
Treatment Research
Prevention Research
Diagnostic Research
Screening Research
Quality of LifeResearch
Genetic studies
Epidemiological studies
Clinical Trials
Others
Base on disease area, clinical research services market is segmented into
Oncology
Central Nervous System Disorders
Cardio Vascular Disorders
Diabetes
Infectious Diseases
Others
Based on end-user, clinical research services market is segmented into
Pharmaceutical Companies
Biotechnological Companies
Research Organizations
Others
Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-PBI-HnM-3219
Clinical research services market is at steady stage of growth. The market is expected to grow at a significant rate during the forecast period. Market players are expanding their markets by offering various services and collaborations. For instance in June 2018, PAREXEL International Corporation, a leading global biopharmaceutical services organization, collaborated with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials. Moreover, In order to maintain market position, companies adopting mergers and acquisitions as their key strategies. For instance, in May, 2018 and inVentiv Health, Inc. and INC Research Holdings, Inc., announced a definitive merger agreement to create a leading biopharmaceutical solutions organization. Similarly, in April 2017, Charles River Laboratories acquired WIL Research to enhance its global footprint, scientific capabilities, and access to growing market segments.
Geographically clinical research services market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America clinical research services market expected to be leading clinical research services market owing to factors such as favourable regulations, developed infrastructure, increase in research and development activities and availability of pool of patients. Europe clinical research services market expected to grow at significant rate owing to increase in R&D activities by pharma and biotechnological companies and favourable regulatory environment and government policies. Asia Pacific region clinical research services market is expected to be fastest growing owing to developing regulatory policies, low cost of the research and availability of a large number of patients.
Some of the players in Clinical Research Services market are Laboratory Corporation Of America Holdings (U.S.), Quintiles Transnational Holdings Inc. (U.S.), PAREXEL International Corporation (U.S.), ICON Plc (Ireland), PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Wuxi AppTec (Cayman) Inc. (China), Pharmaceutical Product Development, LLC (U.S.), INC Research Holdings Inc. (U.S.), and Charles River Laboratories International Inc. (U.S.), to name a few.
In October 2015, WuXi PharmaTech (Cayman) Inc. and Gilead Sciences, Inc., strategically partnered in conducting analytical and stability studies of small-molecule new chemical entities to support global marketing applications and commercial products.
Enquiry for Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-PBI-HnM-3219
Contact Information:
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results